Get the tools used by (smart)2 investors.
Sign In
WatchlistsIdeasScreenerData ExplorerChartsSaved Work

Net Income Forecast (FINBOX) for Iteos Therapeutics Inc

Join now and get access to the full platform

Search for company or ETF

 

  0 results available. Select is focused ,type to refine list, press Down to open the menu,

ITOS: Iteos Therapeutics Inc

iTeos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients with cancer. The company’s lead antibody pro...

- USD
Price
– USD
Fair Value
–
Upside
- - -
52-week range
Create ChartCreate ModelAdd To Watchlist

Analysis

Fiscal Years
Trailing Twelve Months
Fiscal Halfs
Fiscal Quarters
Daily
Hide this widget

The following section summarizes insights on Iteos Therapeutics Inc's Net Income Forecast (FINBOX):

Dec 2026Dec 2028Dec 2030Dec 2032Dec 2034-200 M-100 M0 K100 M200 M300 M
Performance Summary
  • Iteos Therapeutics Inc's net income forecast for the next fiscal year is -176 million
  • Iteos Therapeutics Inc's net income forecast is expected to average -132.2 million over the next 5 fiscal years.
  • Iteos Therapeutics Inc's is expected to deliver median net income forecast of -160.7 million over the next 5 fiscal years.

How does Iteos's Net Income Forecast (FINBOX) benchmark against competitors?

Hide this widget

We've identified the following companies as similar to Iteos Therapeutics Inc because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.

Iteos Net Income Forecast (FINBOX) Benchmarks
NameTickerNet Income Forecast (FINBOX)
Iteos Therapeutics IncNASDAQGM:ITOS-176 M
Arcturus Therapeutics Holdings IncNASDAQGM:ARCT-141.3 M
Geron CorporationNASDAQGS:GERN-85.174 M
Cardiff Oncology IncNASDAQCM:CRDF-59.041 M
Onconetix IncNASDAQCM:ONCO-43.452 M
HealthcareSECTOR:HLTH.US-19.775 M
Trevena IncOTCPK:TRVN-19.648 M
Dyadic International IncNASDAQCM:DYAI-6.205 M
Protalix Biotherapeutics IncNYSEAM:PLX28.513 M
CytomX Therapeutics IncNASDAQGS:CTMX47.006 M
Ainos IncOTCPK:AIMDNA
ADMA Biologics IncNASDAQGM:ADMA175.7 M

Metric Usage: Net Income Forecast

Hide this widget
ni_proj
Slug
number
Datatype
text
Format
current
Default Period
FY, Q
Periods Supported
Free
Plan

To view the full list of supported financial metrics please see Complete Metrics Listing.

Similar Metrics

Search for metric or datapoint

Net Income Forecast

Forecasted net income.

Definition of Net Income Forecast (FINBOX)

Hide this widget
Forecasted net income.

Sector Benchmark Analysis

Sector
Industry Group
Industry
Hide this widget
-294.3 M555.7 M1.406 B3.016 B0200400600800

The chart above depicts the distribution of net income forecast (finbox) for companies operating in the Healthcare sector in the Developed economic region. Over 1,990 companies were considered in this analysis, and 1,919 had meaningful values. The average net income forecast (finbox) of companies in the sector is 54.901 M with a standard deviation of 319.8 M.

Iteos Therapeutics Inc's Net Income Forecast (FINBOX) of -176 M ranks in the 4.4% percentile for the sector. The following table provides additional summary stats:

Net Income Forecast (FINBOX) In The Healthcare Sector
Economic Risk RegionDeveloped
Total Constituents1,999
Included Constituents1,919
Min-298.9 M
Max2.991 B
Median-3.567 M
Mean54.901 M
Standard Deviation319.8 M

You can find companies with similar net income forecast (finbox) using this stock screener.

All rights reserved. Terms Of Use